David Amsellem's Stock Ratings

Piper Sandler Analyst

David Amsellem is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/27/2024

Overall Average Return

9.30%

Smart Score

Overall Average Return Percentile

59th

Number of Ratings

date ▲▼	ticker ▲▼	Buy Now	Company ▲▼	Current price ▲▼	Upside/Downside ▲▼	Analyst Firm ▲▼	Analyst & % Accurate ▲▼	Price Target Change ▲▼	Rating Change ▲▼	Previous / Current Rating ▲▼	Get Alert
04/11/2024	AQST	Buy Now	Aquestive Therapeutics	$3.97	151.89%	Piper Sandler	David Amsellem63%	→ $10	Initiates	→ Overweight	Get Alert
04/01/2024	ALKS	Buy Now	Alkermes	$24.68	58.02%	Piper Sandler	David Amsellem63%	$39 → $39	Reiterates	Overweight → Overweight	Get Alert
03/28/2024	VTRS	Buy Now	Viatris	$11.57	12.36%	Piper Sandler	David Amsellem63%	$11 → $13	Reiterates	Neutral → Neutral	Get Alert
03/21/2024	AMRX	Buy Now	Amneal Pharmaceuticals	$5.74	39.37%	Piper Sandler	David Amsellem63%	$6 → $8	Maintains	Overweight	Get Alert
03/20/2024	JAZZ	Buy Now	Jazz Pharmaceuticals	$109.46	71.75%	Piper Sandler	David Amsellem63%	$171 → $188	Reiterates	Overweight → Overweight	Get Alert
03/05/2024	AVDL	Buy Now	Avadel Pharmaceuticals	$18.00	27.78%	Piper Sandler	David Amsellem63%	$18 → $23	Maintains	Overweight	Get Alert
02/29/2024	RVNC	Buy Now	Revance Therapeutics	$3.40	488.24%	Piper Sandler	David Amsellem63%	$42 → $20	Maintains	Overweight	Get Alert
02/28/2024	SUPN	Buy Now	Supernus Pharmaceuticals	$30.07	36.35%	Piper Sandler	David Amsellem63%	$45 → $41	Maintains	Overweight	Get Alert
02/23/2024	COLL	Buy Now	Collegium Pharmaceutical	$36.42	7.08%	Piper Sandler	David Amsellem63%	$37 → $39	Reiterates	Overweight → Overweight	Get Alert
02/16/2024	ALKS	Buy Now	Alkermes	$24.68	58.02%	Piper Sandler	David Amsellem63%	$35 → $39	Maintains	Overweight	Get Alert
02/16/2024	IRWD	Buy Now	Ironwood Pharmaceuticals	$7.85	167.52%	Piper Sandler	David Amsellem63%	$20 → $21	Maintains	Overweight	Get Alert
02/12/2024	TEVA	Buy Now	Teva Pharmaceutical Indus	$13.89	36.79%	Piper Sandler	David Amsellem63%	$12 → $19	Upgrade	Neutral → Overweight	Get Alert
01/16/2024	AXSM	Buy Now	Axsome Therapeutics	$71.05	59.04%	Piper Sandler	David Amsellem63%	$90 → $113	Maintains	Overweight	Get Alert
01/03/2024	TEVA	Buy Now	Teva Pharmaceutical Indus	$13.89	-13.61%	Piper Sandler	David Amsellem63%	$8 → $12	Upgrade	Underweight → Neutral	Get Alert
12/07/2023	CERE	Buy Now	Cerevel Therapeutics Hldg	$42.70	5.39%	Piper Sandler	David Amsellem63%	$33 → $45	Downgrade	Overweight → Neutral	Get Alert
11/22/2023	VTRS	Buy Now	Viatris	$11.57	-4.93%	Piper Sandler	David Amsellem63%	$10 → $11	Maintains	Neutral	Get Alert
11/22/2023	OGN	Buy Now	Organon	$18.55	18.6%	Piper Sandler	David Amsellem63%	$32 → $22	Maintains	Overweight	Get Alert
11/14/2023	CARA	Buy Now	Cara Therapeutics	$0.68	46.13%	Piper Sandler	David Amsellem63%	$12 → $1	Downgrade	Overweight → Neutral	Get Alert
11/10/2023	XERS	Buy Now	Xeris Biopharma Holdings	$1.75	128.57%	Piper Sandler	David Amsellem63%	$5 → $4	Maintains	Overweight	Get Alert